INTRODUCTION
In accordance with the continuing increases in rates of obesity, the incidence of obesity hypoventilation syndrome (OHS) has also increased. OHS is defined as the combination of obesity (body mass index (BMI) ≥ 30 kg/m 2 ) and chronic daytime hypercapnia (arterial carbon dioxide pressure (PaCO2) ≥ 45 mmHg). 1, 2 In addition, the definition of OHS in previous reports included hypoxemia (arterial oxygen pressure (PaO2) < 70 mmHg). 3, 4 It was reported that the prevalence of OHS in patients with obese obstructive sleep apnoea (OSA) was 10-20% [4] [5] [6] and that 0.3-0.4% of the general population might have OHS. 7, 8 OHS is an entity distinct from OSA or simple obesity and is associated with greater morbidity and mortality than either. 9 Because of cephalometric differences,
OHS may occur at a lower BMI in Asians than in Western individuals, as does OSA. [10] [11] [12] In Japan, Akashiba et al. 10 reported using data from 7 hospitals showing that OSA with hypercapnia was present in 9% of patients with OSA (apnoea- Despite several reports that examined the determinants of PaCO2, diffusion capacity from pulmonary function tests, the disturbance of which is one factor related to hypoxemia, was not measured in previous reports, although hypercapnia with hypoxemia is an important issue in patients with OHS 4 because hypoxemia is uncommon in patients with simple OSA. 4 We hypothesized that the prevalence of OHS in individuals with OSA in Japan was not as high as 9% as previously reported 10 , and that in addition to obesity, other factors were independently associated with PaCO2. We also hypothesized that diffusion capacity, which was not investigated in previous reports, may be an important factor in OHS because it is considered that patients with OHS have a greater degree of hypoxemia than those with simple obesity.
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METHODS (Details are in Online Supporting Information.)
Participants
Participants were consecutively hospitalized in Kyoto University Hospital from October 2008 to September 2012 for a detailed examination for suspected OSA (Fig. 1) . Owing to snoring, witnessed apnoea, daytime sleepiness, obesity, etc. about 60% were self-referrals and 40% were secondary referrals. Our hospital is located in the 7 th largest urban city (Kyoto) in Japan and adjacent to the 3 rd (Osaka) and 6 th (Kobe) largest cities.
From the address of the participants, at least 90% were from urban areas. We based the diagnosis of OHS on a BMI ≥ 30 kg/m 2 and PaCO2 ≥ 45 mmHg and that of hypoxemic OHS on a BMI ≥ 30 kg/m 2 , PaCO2 ≥ 45 mmHg, and PaO2 < 70 mmHg.
The study protocol was approved by the Kyoto University Graduate School and Faculty of Medicine Ethics Committee (approved number: E566). Informed consent was obtained from all patients. This clinical trial was registered in UMIN (reference number: UMIN000001931).
Polysomnography
Diagnosis of OSA was confirmed by polysomnography (SomnoStar pro, Cardinal
Health, Dublin, OH, USA) as previously reported. 13 Apnoea was defined as the complete cessation of airflow for at least 10 seconds and hypopnoea as a decrease in airflow of 50% or more lasting for at least 10 seconds, accompanied by oxygen desaturation of ≥ 3% or an arousal. 14 The 4% oxygen desaturation index (ODI) was determined by the frequency of desaturations of ≥ 4% per hour.
Assessment of pulmonary function
Pulmonary function tests were performed using a standard spirometer, according to the recommended method. 15 The values for carbon monoxide diffusing capacity (DLco) adjusted for hemoglobin were calculated.
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Laboratory analyses of blood
Arterial blood for blood gas analysis was drawn under room air conditions just before polysomnography started at night with the participants in the supine position that was maintained for 20 minutes before arterial blood was drawn.
Statistical analysis
Baseline characteristics are expressed as mean values with standard deviation (SD) or numbers. Normality and homogeneity of variance assumptions were checked before further analyses. After normality testing, all the variables were treated as parametric.
Unpaired t-tests and chi-square tests were used to compare the backgrounds of two groups. In addition, the analysis of a covariance model adjusted for waist circumference was used to compare two groups. Relationships between two sets of continuous data were analyzed by Pearson's correlation coefficient tests and those of dichotomous data were analyzed by Spearman rank correlation coefficient. P values < 0.05 were considered to be statistically significant. Multiple regression analyses, with a P value < 0.10 for entry into the models, were performed to identify variables that could be best associated with PaCO2. Statistical analyses were performed using Statview 5.0 (SAS Institute, Inc. Cary, NC, USA).
RESULTS (Details are in Online Supporting Information.)
Characteristics of participants
Of the 1127 patients assessed for suspected OSA, 981 participants (673 males and 308 females) were entered into the study (Fig. 1 ). In the excluded groups, there were 2 non-obese sever chronic obstructive pulmonary disease (COPD) patients (Fig. 1 ). More than 95% (20/21) of the OHS patients had OSA (AHI ≥ 5 /h). 
Comparison between OHS and non-OHS in obese OSA
Prevalence of OHS regarding the degree of obesity
The prevalence of OHS in the patients with a BMI 30-34.9 kg/m 2 was 6.8%, and that with a BMI ≥ 35 kg/m2 comprised 3.9%
of the Japanese population. 17 We estimated that about 0.48% of the population in Japan might have OHS. When we compared OHS patients with and without hypoxemia, DLco was significantly lower in the hypoxemic OHS patients (79.7±19.0%) than in those without hypoxemia (96.4±8.4%) (P = 0.033) ( Table S1 ).
Multiple regression analysis to identify independent determinants of CO2 accumulation in obese OSA
PaCO2 had significant and independent associations not only with waist circumference (contribution rate (R 2 ) = 4.9%) but also with PaO2 (R 2 = 7.7%), 4%ODI (R 2 = 8.9%), DLco/ alveolar volume (VA) (R 2 = 8.3%) and hemoglobin (R 2 = 4.9%) ( Table 3 and Fig. 3). Among those variables, strong co-linearity was not found (Table S3) . When using AHI, instead of 4%ODI, PaCO2 had significant and independent associations with the same factors.
Improvements in arterial blood gas after CPAP treatment
Of the 20 OHS patients with OSA, 18 OHS patients were introduced to CPAP treatment.
to provide arterial blood samples for blood gas analyses after CPAP treatment. Finally,
we assessed data on 14 OHS patients with OSA that were obtained before and after CPAP treatment (Fig. S1 ).
In the 14 patients, PaCO2 significantly improved after more than 6 months of CPAP treatment (treatment duration; 12.3±4.6 mo) ( Table 4 ). In 12 of the 14 OHS patients (85.7%), PaCO2 improved and more than 60% of those patients (9/14) had PaCO2 < 45 mmHg. Differences between before and after CPAP treatment in 4%ODI and those in PaCO2 were significantly correlated (r = 0.69, P = 0.005) (Fig. 4A ).
Objective data on adherence indicated that CPAP adherence among the 14 patients was 3.0 h/day. Differences between before and after CPAP treatment in PaCO2 and CPAP adherence estimated for the month when arterial blood was drawn were significantly correlated (r = 0.62, P = 0.016 ) (Fig. 4B ).
DISCUSSIONS
In our study, the prevalence of OHS in OSA (AHI ≥ 5 /h) was not 9% 10 but 2.3%, while
Akashiba et al. used a different definition (AHI ≥ 20 /h on CPAP treatment) 10 . Also, the prevalence of OHS in obese OSA (12.3%) was estimated to be the same as in the West, but the mean BMI in patients with OHS in our study (36.7 kg/m 2 ) was lower than that in
Western countries (44 kg/m 2 ). 5, 18 Multiple regression analysis revealed that, in addition to waist circumference, DLco/VA and hemoglobin level, PaO2 while awake and 4%ODI
were independently associated with PaCO2.
It is said that the prevalence of OHS in patients with OSA in Japan was 9% 10 and several reviews quoted that percentage as the prevalence of OHS in OSA in an Asian country (Japan). In addition to the fact that the participants were not consecutively enrolled and the data were acquired 10 years ago, it is highly important to consider that the definition of OHS in OSA in that report was not BMI ≥ 30 kg/m 2 , AHI ≥ 5 /h and PaCO2 ≥ 45 mmHg, which is usually recognized as the definition of OHS in OSA, but AHI ≥ 20 /h under CPAP treatment and PaCO2 ≥ 45 mmHg. From our consecutive data from one hospital in Japan, the prevalence of OHS in OSA (AHI ≥ 5 /h) was 2.3%.
Although the prevalence of OHS in individuals with OSA was lower than previously reported, 5 that of OHS in obese OSA (BMI ≥ 30 kg/m 2 and AHI ≥ 5 /h) was 12.3%, which was close to the frequency cited in previous reports. 5, 6, 18 It has been reported that individuals with a BMI ≥ 30 kg/m 2 comprised 3.9% of the Kaw et al. found that severity of obesity, severity of OSA, and pulmonary restrictive impairment were risk factors for hypercapnia. 7 Two previous reports from Japan 21, 22 showed that not obesity but OSA related to AHI, nocturnal desaturation and pulmonary impairment play major roles in the cause of hypercapnia as indicated by some of the parameters in this study. This is the first report to reveal that DLco/VA was a significant determinant of hypercapnia in OHS. Obese patients have a high cardiac output and elevated total and central blood volume, which increase central circulatory congestion and capillary blood volume and result in elevations in DLco/VA. [23] [24] [25] In addition, the low lung volume in the patients with OHS which was reported previously 9,26 also might induce high DLco/VA.
However, it should be noted that DLco/VA might produce a large number of false negative results, particularly in those with a low lung volume. In addition, whether this is an epiphenomenon or represents a genuine aspect of pathophysiology is unclear and needs further investigation.
Elevated hemoglobin in the OHS patients might be due to severe sustained desaturation during sleep (SpO2 < 90 (% total sleep time)). Recent data showed that sustained hypoxia induced increases in hemoglobin through hypoxia inducible factor-1. 27 Further research on the relationship between secondary polycythemia and hypercapnia in OSA should be done in the future.
Our results also implied that abdominal obesity, as assessed by waist circumference, has an independent effect on hypoventilation as previously reported. 28 Abdominal obesity with increased waist circumference effected a restrictive respiratory impairment, which was associated with a reduction in PaO2, 29,30 inducing daytime hypoxemia. 31 Our results could be important because hypoxemia induced by hypercapnia might worsen the hypercapnia and vice versa.
In our study, 4%ODI was independently associated with PaCO2 (Table 3 ). In addition, the degrees of improvement in the 4%ODI with CPAP treatment were significantly associated with those in PaCO2 levels (Fig. 4A ). These data indicate that OSA induced worse awake PaCO2 levels in patients with OSA.
In our study, obese OSA patients with OHS had a larger waist circumference, presenting a greater restrictive load, than those without OHS (Table 2) although there was no difference in neck circumference. In this study, OHS patients seemed to be more amenable to correction of PaCO2 levels by CPAP treatment, which might be due to a lesser restrictive load with a lower BMI compared to the higher BMI in Western patients with OHS, along with the correction of upper airway collapse.
Our study had some limitations. First, it came from a single center. Second, the number of patients with OHS was small, although the analysis included a large number of patients (n = 981). Therefore, the conclusions should be viewed with caution. Third, OSA can coexist with COPD and causes greater oxygen desaturation and potential pulmonary hypertension. Thus, the true prevalence of OHS may be underestimated by excluding patients with COPD. However, in this study, since there were only 2 severe COPD patients and they were not obese, the effects of COPD with hypercapnia on the results of this study were slight.
In conclusion, the prevalence of OHS in Japan seems to be the same as in the West, even though the degree of obesity is less. In our patients with OHS, both sleep apnoea and diurnal oxygenation were independently associated with PaCO2 in addition to increases in DLco/VA. In our study, contribution rates of PaO2 or 4%ODI to the variations in PaCO2 were lower than in previous reports, which might be due to racial differences among participants. For this reason, further studies are needed to examine differences in the pathophysiology of OHS according to racial and ethnic groups. •：results from our study, ○：results from the report by 
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